Division of Translational Cancer Research
1 – 10 of 690
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Dynamic assessment of proliferation to guide response-adapted therapy in the setting of neoadjuvant chemotherapy in ER+/HER2- breast cancer
- Contribution to journal › Article
-
Mark
Systemic and local decorin levels mirror the clinical course of pancreatic cancer
- Contribution to journal › Article
- 2025
-
Mark
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
- Contribution to journal › Article
-
Mark
The DNA methylation landscape of primary triple-negative breast cancer
- Contribution to journal › Article
-
Mark
Genomic Characteristics Related to Histology-based Immune Features in Breast Cancer
(2025) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 38(5).
- Contribution to journal › Article
-
Mark
Outcome prediction of prostate cancer patients on active surveillance using weakly supervised deep learning
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post-Initiation of Androgen Deprivation Therapy
- Contribution to journal › Article
-
Mark
A two-phase epigenome-wide four-way gene–smoking interaction study of overall survival for early-stage non-small cell lung cancer
- Contribution to journal › Article
-
Mark
Stand-alone transcriptional immune response prediction in primary triple-negative breast cancer
- Contribution to journal › Article
-
Mark
Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics
- Contribution to journal › Article
